You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Department of Cancer Immunology and AIDS at Dana-Farber will use the synthetic biology platform as part of research to develop transient immunity against life-threatening viral infections.
The firms have formalized a supply deal, under which Sequenom and its subsidiaries will purchase Illumina sequencing products for use in developing its non-invasive trisomy 21 test.
Scienion will produce protein microarray batches of more than 1,000 arrays for Protagen for the clinical validation of biomarker panels.
The two-year agreement, which took effect in March 2009 to substantiate CDI's iCell Cardiomyocytes as a predictive tool, was completed early, and the platform will now be incorporated into Roche's drug development decision-making process.
IMDx received access to patents covering Biosearch's BHQ, CAL Fluor, and Quasar technologies.
The firm will be a preferred supplier of synthetic oligonucleotides to Research Councils UK Shared Services Centre Ltd.
The German firm will provide synthetic oligos to the RCUK Shared Services Centre Ltd.
Abbott's PathVysion FISH assay will be used to develop the test on Leica's BOND platform.
Affymetrix will use TriLink Biotechnologies' oligonucleotides in several of its kits.
Under the contract, Integrated DNA Technologies will supply the Research Councils UK with synthetic oligonucleotides.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.